Our Company

We are focused on connecting innovation to purpose.

Corbus is a precision oncology company committed to helping people defeat serious illness by bringing innovative scientific approaches to well understood biological pathways. Corbus’ internal development pipeline includes CRB-701, a next generation antibody drug conjugate (ADC) that targets the expression of Nectin 4-on cancer cells to release a cytotoxic payload and CRB-601, and anti-integrin monoclonal antibody which blocks the activation of TGFβ expressed on cancer cells.

Corbus is based in Norwood, Massachusetts.

Corbus Core Values

HUMILITY

We value others by showing respect to one another and ensuring all perspectives are heard. We remain focused on the patient, recognizing that our work serves a greater purpose.

TEAMWORK

We embrace mutual accountability and rely on one another to achieve shared objectives. This collaborative spirit strengthens relationships and enhances our ability to achieve our goals.

THINKING OUTSIDE THE BOX

We encourage creativity and unconventional approaches to problem-solving We believe that diverse perspectives lead to innovative solutions.

RESILIENCE

We are persistent and adaptable, overcoming obstacles with determination and a commitment to empowering each other.